FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2131741738> ?p ?o ?g. }

• W2131741738 endingPage "420" @default.
• W2131741738 startingPage "400" @default.
• W2131741738 abstract "Annals of the New York Academy of SciencesVolume 201, Issue 1 p. 400-420 PLATELET ABNORMALITIES IN VON WILLEBRAND'S DISEASE* E. J. Walter Bowie, E. J. Walter Bowie Mayo Clinic and Mayo Foundation Rochester, Minnesota 55901Search for more papers by this authorCharles A. Owen Jr., Charles A. Owen Jr. Mayo Clinic and Mayo Foundation Rochester, Minnesota 55901Search for more papers by this author E. J. Walter Bowie, E. J. Walter Bowie Mayo Clinic and Mayo Foundation Rochester, Minnesota 55901Search for more papers by this authorCharles A. Owen Jr., Charles A. Owen Jr. Mayo Clinic and Mayo Foundation Rochester, Minnesota 55901Search for more papers by this author First published: October 1972 https://doi.org/10.1111/j.1749-6632.1972.tb16313.xCitations: 9 † This investigation was supported in part by Research Grant HE-12512 from the National Institutes of Health, Public Health Service, Bethesda, Md. AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL References 1 Jaques, L. B. 1962. Spontaneous hemorrhage with anticoagulants. Circulation 25: 130. 2 V. Willebrand, E. A. 1926. Hereditär pseudohemofili. Finska Lak.-Sallsk. Handl. 68: 87. 3 Morawitz, P. & R. Jüürgens. 1930. Gibt es eine Thrombasthenie Munch. Med. Wochenschr. 2: 2001. 4 Jüürgens, R. 1937. Die erblichen Thrombopathien. Ergeb. Inn. Med. Kinderheilkd. 53: 795. 5 V. Willebrand, E. A. & R. Jürgens 1933. Über ein neues vererbbares Blutungsübel: die konstitutionelle Thrombopathie. Dtsch. Arch. Klin. Med. 175: 453. 6 V. Willebrand, E. A. & R. Jürgens 1933. Über eine neue Bluterkrankheit, die konstitutionelle Thrombopathie. Klin. Wochenschr. 12: 414. 7 V. Willebrand, E. A. R. Jürgens & U. Dahlberg 1934. Konstitutionell trombopati, en ny ärftlig blödarsjukdom. Finska Lak.-Sallsk. Handl. 76: 193. 8 Lehmann, W. 1959. Neuere Untersuchungen zur Thrombopathie (v. Willebrand-JÜRGENS) auf den Åland-Inseln (Finnland). Acta Genet. Med. Gemellol. (Roma) 8 (Suppl. 2): 38. 9 Raccuglia, G. & J. V. Neel. 1960. Congenital vascular defect associated with platelet abnormality and antihemophilic factor deficiency. Blood 15: 807. 10 Schulz, H., R. Jürgens & E. Hiepler. 1958. Die Ultrastruktur der Thrombozyten bei der konstitutionellen Thrombopathie (v. Willebrand-JÜRGENS) mit einem Beitrag zur submikroskopischen Orthologie der Thrombozyten. Thromb. Diath. Haemorrh. 2: 300. 11 Eriksson, A. W., E. Hiepler, R. Jürgens, W. Lehmann & H. Schulz. 1961. Untersuchungen zur Thrombopathie (v. Willebrand-Jürgens). Klin. Wochenschr. 39: 32. 12 Jean, G., L. Racine, A. Gautier & R. Marx. 1963. Granulations denses anormales dans les thrombocytes humains. Thromb. Diath. Haemorrh. 10: 42. 13 Lechner, K., L. Stockinger & J. Graf. 1967. Elektronenmikroskopische Untersuchungen an Thrombozyten von Patienten mit Thrombopathien. Thromb. Diath. Haemorrh. (suppl.) 24: 175. 14 Marx, R. & G. Jean. 1964. Zur Pathogenese der v. Willebrand-Jürgens Syndrome: eine klinische und submikroskopische Studie. Klin. Wochenschr. 42: 491. 15 Jürgens, J. 1968. Zur Klinik der von Willebrand-JÜRGENS-Syndrome. Blut Z. Ges. Blutforsch. 6: 164. 16 Ulutin, O. N. 1958. Haemophilia-like states in girls. (Letter to the editor) Lancet 2: 591. 17 Blombäck, M., J. E. Jorpes & I. M. Nilsson. 1963. Von Willebrand's disease. Am. J. Med. 34: 236. 18 Estren, S., L. Sanchez-Médal & W. Dameshek 1946. Pseudohemophilia. Blood 1: 504. 19 Nilsson, I. M. & M. Blomback. 1963. Von Willebrand's disease in Sweden: occurrence, pathogenesis and treatment. Thromb. Diath. Haemorrh. 9 (Suppl. 11): 103. 20 Revol, L., J. Favre-Gilly & C. Ollagnier 1950. La maladie de Willebrand: thrombopathie constitutionnelle ou pseudo-hëmophilie. Rev. Hematol. 5: 24. 21 Ten, Cate, J. W. 1971. Platelet functions in relation to haemostasis. Thesis: 75. University of Amsterdam, The Netherlands. 22 Borchgrevink, C. F. 1960. A method for measuring platelet adhesiveness in vivo. Acta Med. Scand. 168: 157. 23 Didisheim, P. & D. Bunting. 1966. Abnormal platelet function in myelofibrosis. Am. J. Clin. Pathol. 45: 566. 24 Wright, H. P. 1941. The adhesiveness of blood platelets in normal subjects with varying concentrations of anticoagulants. J. Pathol. 53: 255. 25 Moolten, S. E. & L. Vroman. 1949. The adhesiveness of blood platelets in thrombo-embolism and hemorrhagic disorders. I. Measurement of platelet adhesiveness by the glass-wool filter. Am. J. Clin. Pathol. 19: 701. 26 Hellem, A. J. 1960. The adhesiveness of human blood platelets in vitro. Scand. J. Clin. Lab. Invest. 12(Suppl. 51): 1. 27 Breddin, K. 1964. Zur Messung der Thrombozyten-adhäsivität. Thromb. Diath. Haemorrh. 12: 269. 28 Hardisty, R. M., K. M. Dormandy & R. A. Hutton. 1964. Thrombasthenia: studies on three cases. Brit. J. Haematol. 10: 371. 29 Salzman, E. W. 1963. Measurement of platelet adhesiveness: a simple in vitro technique demonstrating an abnormality in von Willebrand's disease. J. Lab. Clin. Med. 62: 724. 30 Bowie, E. J. W., C. A. Owen, Jr., J. H. Thompson, Jr. & P. Didisheim. 1969. A test of platelet adhesiveness. Mayo Clin. Proc. 44: 306. 31 Bowie, E. J. W., C. A. Owen, Jr., J. H. Thompson, Jr. & P. Didisheim. 1969. Platelet adhesiveness in von Willebrand's disease. Am. J. Clin. Pathol. 52: 69. 32 Jürgens, R. & H. Forsius. 1951. Untersuchungen über die “konstitutionelle Thrombopathie (v. Willebrand-Jürgens)” auf den Ålandsinseln. Schweiz. Med. Wochenschr. 81: 1248. 33 Fortunato, F. 1951. Nuovo contributo alio studio delle trombopatie. Clin. Pediat. (Bologna) 33: 201. 34 Borchgrevink, C. F. 1961. Platelet adhesion in vivo in patients with bleeding disorders. Acta Med. Scand. 170: 231. 35 Caen, J. & C. Cousin. 1962. Le trouble ďadhésivité“in vivo” des plaquettes dans la maladie de Willebrand et les thrombasthénies de Glanzmann. Nouv. Rev. Fr. Hematol. 2: 685. 36 Cornu, P. & J. Bernard. 1963. Ľallongement du temps de saignement dans la maladie de Willebrand. Nouv. Rev. Fr. Hematol. 3: 321. 37 Cornu, P., M.-J. Larrieu, J. Caen & J. Bernard 1961. Maladie de Willebrand: étude clinique, génétique et biologique; a propos de 22 observations. Nouv. Rev. Franc. Hematol. 1: 231. 38 Lehmann, W., J. Jürgens & A. W. Eriksson. 1964. The platelet function of the thrombopathy on the Åland Islands. Thromb. Diath. Haemorrh. 12: 148. 39 Quick, A. J. 1965. Hereditary thrombopathic thrombocytopenia and Minot-von Willebrand syndrome: probable co-existence in a family. Am. J. Med. Sci. 250: 1. 40 Ulutin, O. N., A. Ü. Müftüoglu, G. Erdogan, T. Erbengi, Y. Tangün, E. ÖZkan, S. Erdem & A. Görpe 1965. Von Willebrand's disease: a case study. New Istanbul Contrib. Clin. Sci. 8: 166. 41 Weiss, H. J. 1962. The use of plasma and plasma fractions in the treatment of a patient with von Willebrand's disease. Vox Sang 7: 267. 42 Bowie, E. J. W., P. Didisheim, J. H. Thompson, Jr. & C. A. Owen, Jr. 1967. The spectrum of von Willebrand's disease. Thromb. Diath. Haemorrh. 18: 40. 43 Jørgensen, L, & C. F. Borchgrevink. 1964. The haemostatic mechanism in patients with haemorrhagic diseases: a histological study of wounds made for primary and secondary bleeding time tests. Acta Pathol. Microbiol. Scand. [A] 60: 55. 44 Leslie, J. 1967. Bleeding time and in vivo platelet adhesiveness in von Willebrand's disease: effect of iontophoresis of adenosine diphosphate. (Letter to the editor) Nature (London) 215: 1302. 45 O'Brien, J. R. 1961. The adhesiveness of native platelets and its prevention. J. Clin. Pathol. 14: 140. 46 Cronberg, S., I. M. Nilsson & J. Silwer. 1966. Studies on the platelet adhesiveness in von Willebrand's disease. Acta Med. Scand. 180: 43. 47 Zucker, M. B. 1963. Haematology: in vitro abnormality of the blood in von Willebrand's disease correctable by normal plasma. (Letter to the editor) Nature (London) 197: 601. 48 Strauss, H. S. & G. E. Bloom. 1965. Von Willebrand's disease: use of a platelet-adhesiveness test in diagnosis and family investigation. New Eng. J. Med. 273: 171. 49 Meyer, D., M.-J. Larrieu, P. Maroteaux & J. P. Caen. 1967. Biological findings in von Willebrand's pedigrees: implications for inheritance. J. Clin. Pathol. 20: 190. 50 Weiss, H. J. 1968. Von Willebrand's disease: diagnostic criteria. Blood 32: 668. 51 Murphy, E. A. 1969. Von Willebrand's disease: statistical evaluation of the glass bead test in diagnosis; preliminary report. Thromb. Diath. Haemorrh. (suppl.) 35: 211. 52 O'Brien, J. R. & J. B. Heywood. 1967. Some interactions between human platelets and glass: von Willebrand's disease compared with normal. J. Clin. Pathol. 20: 56. 53 Coller, B. S. & M. B. Zucker. 1971. Reversible decrease in platelet retention by glass bead columns (adhesiveness) induced by disturbing the blood. Proc. Soc. Exp. Biol. Med. 136: 769. 54 Friedberg, N. M., M. B. Zucker, R. A. Grant & S. J. Kim. 1971. Platelet retention in glass bead columns: reversal of adenine nucleotide-induced inhibition by apyrase. Fed. Proc. 30(Abstr.): 423. 55 Bowie, E. J. W. & C. A. Owen, Jr. 1971. Some factors influencing platelet retention in glass bead columns including the influence of plastics. Am. J. Clin. Pathol. 56: 479. 56 Salzman, E. W. & A. Britten. 1964. In vitro correction of defective platelet adhesive-ness in von Willebrand's disease. Fed. Proc. 23(Abstr.): 239. 57 ÖDegaard, A. E., B. A. Skålhegg & A. J. Hellem. 1964. Increased activity of “anti-Willebrand factor” in diabetic plasma. Thromb. Diath. Haemorrh. 11: 27. 58 Larrieu, M.-J., J. P. Caen, D. O. Meyer, H. Vainer, Y. Sultan & J. Bernard. 1968. Congenital bleeding disorders with long bleeding time and normal platelet count. II. Von Willebrand's disease: report of thirty-seven patients. Am. J. Med. 45: 354. 59 Akman, N., G. Bayrak, B. Berkarda & O. N. Ulutin. 1965. The effect of oestradiol succinate on in vivo platelet adhesion. New Istanbul Contrib. Clin. Sci. 8: 106. 60 Glueck, H. I. & H. Flessa. 1967. The control of hemorrhage with a combination of norethynodrel-mestranol. (Abstr.) J. Lab. Clin. Med. 70: 877. 61 Meyer, D. & M.-J. Larrieu. 1970. Von Willebrand factor and platelet adhesiveness. J. Clin. Pathol. 23: 228. 62 Jürgens, J., W. Lehmann & A. Eriksson. 1966. The platelet aggregation defect in the von Willebrand-Jürgens syndrome on the Aland Islands: the possible existence of an “anti-Willebrand-factor.” Hemostase 6: 225. 63 ÖDegaard, A. E., B. A. Skålhegg & A. J. Hellem. 1964. ADP-induced platelet adhesiveness as a diagnostic test in von Willebrand's disease. Thromb. Diath. Haemorrh. 11: 23. 64 Vainer, H. & J. Caen. 1963. Utilisation ďun test photomérique pour ľétude de ľeffet de ľADP sur les plaquettes sanguines. Nouv. Rev. Franc. Hematol. 3: 149. 65 Bouma, B. N., Y., Wiegerinck, J. J., Sixma, J. A. Van Mourik & I. A. Mochtar. Immunological characterization of purified antihaemophilic factor A (factor VIII) with correcting activity on the platelet retention in a glass-bead column in von Willebrand's disease. Nature (London). In press. 66 Weiss, H. J. 1967. Platelet aggregation, adhesion and adenosine diphosphate release in thrombopathia (platelet factor 3 deficiency): a comparison with Glanzmann's thrombasthenia and von Willebrand's disease. Am. J. Med. 43: 570. 67 Weiss, H. J., P. A. Chervenick, R. Zalusky & A. Factor. 1969. A familial defect in platelet function associated with impaired release of adenosine diphosphate. New Eng. J. Med. 281: 1264. 68 Simone, J. V., J. A. Cornet & C. F. Abildgaard. 1968. Acquired von Willebrand's syndrome in systemic lupus erythematosus. Blood 31: 806. 69 Ingram, G. I. C, P. J. Kingston, J. Leslie & E. J. W. Bowie. 1971. Three cases of acquired von Willebrand's syndrome. Brit. J. Haematol. 21: 189. 70 Geiger, A. J. & A. G. Evans. 1938. Atypical hereditary hemorrhagic syndromes. Int. Clin. 2: 135. 71 Schulman, I., C. H. Smith, M. Erlandson & E. Fort. 1955. Vascular hemophilia: a familial hemorrhagic disease in males and females characterized by combined antihemophilic globulin deficiency and vascular abnormality. (Abstr.) Am. J. Dis. Child. 90: 526. 72 Nilsson, I. M., B. Blombäck, M. Blombäck & S. Svennerud. 1956. Kvinnlig hämofili och dess behandling med humant antihämofiliglobulin. Nord. Med. 56: 1654. 73 Blombäck, M. 1958. Studies on antihemophilic globulin (summary of Suppl. 114). Acta Paediat. Scand. 47: 709. 74 Blombäck, M., B. Blombäck & I. M. Nilsson. 1964. Response to fractions in von Willebrand's disease. In The Hemophilias. K. M. Brinkhous, Ed.: 286– 294. International Symposium, Washington, D.C. 1963. University of North Carolina Press. Chapel Hill , N. C. 75 Nilsson, I. M. 1957. Ein Fall weiblicher Hämophilie und dessen Behandlung mit speziell hergestelltem, menschlichem Antihämophilieglobulin. In Nebenwirkungen von Arzneimitteln auf Blut und Knochenmark. R. Jürgens, Ed.: 246– 252. Internationales Symposium, Malmö, Sweden . Schattauer. Stuttgart , Germany . 76 Nilsson, I. M. & M. Blombäck. 1959. The pathogenesis and treatment of v. Willebrand's disease. In Hemophilia and Other Hemorrhagic States. K. M. Brinkhous, Ed.: 93– 99. International Symposium, Rome, 1958. University of North Carolina Press. Chapel Hill , N. C. . 77 Nilsson, I. M., M. Blombäck & B. Blombäck. 1959. V. Willebrand's disease in Sweden: its pathogenesis and treatment. Acta Med. Scand. 164: 263. 78 Nilsson, I. M., M. Blombäck & B. Blombäck. 1960. The use of human antihaemophilic globulin (fraction I-O) in haemophilia A and in von Willebrand's disease. Acta Haematol. (Basel) 24: 116. 79 Nilsson, I. M., M. Blombäck, E. Jorpes, B. Blombäck & S.-A. Johansson. 1957. V. Willebrand's disease and its correction with human plasma fraction I-O. Acta Med. Scand. 159: 179. 80 Nilsson, I. M., M. Blombäck & I. von Francken. 1958. On an inherited autosomal haemorrhagic diathesis with antihaemophilic globulin deficiency and prolonged bleeding time. In Proceedings of the Sixth Congress of the European Society of Haematology. Copenhagen, Denmark, 1957. A. Videbaek, Ed.. Vol. 2: 629– 634. S. Karger AG. Basel , Switzerland . 81 Nilsson, I. M., M. Blombäck & I. von Francken. 1957. On an inherited autosomal hemorrhagic diathesis with antihemophilic globulin (AHG) deficiency and prolonged bleeding time. Acta Med. Scand. 159: 35. 82 Van Creveld, S. & I. A. Mochtar. 1960. Von Willebrand's disease: a plasma deficiency cause of the prolonged bleeding time. Ann. Paediat. (Basel) 194: 37. 83 Cornu, P., M.-J. Larrieu, J. Caen & J. Bernard 1963. Transfusion studies in von Willebrand's disease: effect on bleeding time and factor VIII. Brit. J. Haematol. 9: 189. 84 White, J. G., E. Yunis, M. Colliander & W. Krivit. 1963. Prolonged bleeding time in a patient with plasma thromboplastin antecedent deficiency: observations on correction of the bleeding time by platelet transfusion. J. Pediat. 63: 1081. 85 Magnusson, S. 1963. Discussion. Thromb. Diath. Haemorrh. 9(Suppl. 11): 126. 86 Perkins, H. A. 1967. Correction of the hemostatic defects in von Willebrand's disease. Blood 30: 375. 87 Weiss, H. J. 1962. The use of Cohn fraction I from diverse sources in the therapy of von Willebrand's disease. Vox Sang 7: 97. 88 Yoshida, K. & H. Fukui. 1965. Deficiency of plasma antibleeding factor (Nilsson) in vascular hemophilia B and pure vascular pseudohemophilia. Isr. J. Med. Sci. 1: 851. 89 Valberg, L. S. & G. M. Brown. 1958. Haemorrhagic capillary disorder associated with antihaemophilic globulin deficiency. Medicine (Baltimore) 37: 181. 90 Owen, C. A., Jr., E. J. W. Bowie, P. Didisheim & J. H. Thompson, Jr. 1970. The pathophysiology of von Willebrand's disease. K. M. Brinkhous, Ed.: 187– 204. In Hemophilia and New Hemorrhagic States. International Symposium, New York, 1968. University of North Carolina Press. Chapel Hill , North Carolina . 91 Duke, W. W. 1910. The relation of blood platelets to hemorrhagic disease: description of a method for determining the bleeding time and coagulation time and report of three cases of hemorrhagic disease relieved by transfusion. JAMA 55: 1185. 92 Ivy, A. C, P. F. Shapiro & P. Melnick. 1935. The bleeding tendency in jaundice. Surg. Gynecol. Obstet. 60: 781. 93 Sutor, A. H., E. J. W. Bowie, J. H. Thompson, Jr., P. Didisheim, B. F. Mertens & C. A. Owen, Jr. 1971. Bleeding from standardized skin punctures: automated technic for recording time, intensity, and pattern of bleeding. Am. J. Clin. Pathol. 55: 541. 94 Bowie, E. J. W. C., A. Owen, Jr., R., J., Hansen & J. Isaacson. Electronic method for quantitation of bleeding time. Am. J. Clin. Pathol. In press. 95 Sutor, A. H., E. J. W. Bowie & C. A. Owen, Jr. 1971. A new method of demonstrating the effect of therapy in von Willebrand's disease. Mayo Clin. Proc. 46: 345. 96 Sutor, A. H., E. J. W. Bowie & C. A. Owen, Jr. 1971. Effect of temperature on hemostasis: a cold-tolerance test. Blut 22: 27. 97 Sutor, A. H., E. J. W. Bowie & C. A. Owen, Jr. 1971. Effect of aspirin, sodium salicylate, and acetaminophen on bleeding. Mayo Clin. Proc. 46: 178. 98 Quick, A. J. 1966. Salicylates and bleeding: the aspirin tolerance test. Am. J. Med. Sci. 252: 265. 99 O'Brien, J. R. 1966. Platelet-glass reactions in von Willebrand's disease. In Abstracts of Papers of the XIth Congress of the International Society of Haematology: 183. Government Printing. Sydney , Australia . 100 Hardisty, R. M. 1968. Platelet function. (Letter to the editor) Lancet i: 419. 101 Van Creveld, S. & C. N. Pascha. 1968. Abnormality in the aggregation of blood platelets in various morbid conditions and the influence of prostaglandins upon this abnormality. Thromb. Diath. Haemorrh. 20: 180. 102 Holdrinet, A., M. Ewals & C. Haanen. 1968. Platelet function and von Willebrand's disease. (Letter to the editor) Lancet i: 1150. 103 Sinakos, Z., Y. Sultan, J. Caen & J. Bernard. 1967. Le comportement des plaquettes dans les maladies hémorragiques. Presse Med. 75: 269. 104 Caen, J. P. 1963. Ratio adenosine triphosphate/adenosine diphosphate in platelet-rich plasma in haemorrhagic disorders (von Willebrand and Glanzmann disease). (Letter to the editor.) Nature (London) 197: 504. 105 Elödi, S. & G. Králl. 1969. Studies on platelet functions in different platelet disorders. Haematologica 3: 299. 106 Vainer, H. & J. P. Caen. 1964. A useful photometric test for the diagnosis of von Willebrand's disease. J. Clin. Pathol. 17: 191. 107 Holdrinet, A., M. Ewals & C. Haanen. 1969. A simple test for measuring platelet aggregation results in von Willebrand's disease and uraemia. Thromb. Diath. Haemorrh. 22: 174. 108 Feissly, R. & H. Lüdin. 1949. Microscopie par contrastes de phases. III. Applications a ľhématologie. Rev. Hematol. 4: 481. 109 De Maat, C. E. M. & A. E. Starkenburg. 1968. Pseudo thrombocytopenia using the Feissly-Lüdin platelet counting technique in von Willebrand's disease and other states. (Abstr.) In Proceedings of the XIIth Congress of the International Society of Hematology (Abstracts of the Simultaneous Sessions): 206. New York , N. Y. 110 Brüster, H. 1964. Discussion. In The Hemophilias. K. M. Brinkhous, Ed.: 306– 309. International Symposium, Washington, D. C. 1963. North Carolina Press. Chapel Hill , N. C. 111 Deutsch, E. 1957. Eine neue Thrombopathie-Familie. Thromb. Diath. Haemorrh. 1: 261. 112 Eriksson, A. W. 1961. Eine neue Blutersippe mit v. Willebrand-JÜRGENS' scher Krankheit (erbliche Thrombopathie) auf Åland (Finnland). Acta Genet. Med. Gemellol. (Roma) 10: 157. 113 Gouttas, A., H. Tsevrenis, C. Rombos & F. Fessas. 1952. Deux cas de thrombopathies type Willebrand-Jürgens. Sang 23: 328. 114 Johnson, S. A., R. W. Monto & J. W. Rebuck. 1957. The nature of the coagulation defect in pseudohemophilia B. (Abstr.) Clin. Res. Proc. 5: 291. 115 Lewis. J. H., 1964. Synthesis of AHF in von Willebrand's disease. Blood 23: 233. 116 Ulutin, O. N. 1961. The qualitative platelet diseases. In Blood Platelets. S. A. Johnson, R. W. Monto, J. W. Rebuck & R. C. Horn, Eds. 553– 563. Henry Ford Hospital International Symposium. Detroit , Mich. , 1960. Little, Brown. Boston , Mass . 117 Ulutin, O. N. & M. Karaca. 1959. A study on the pathogenesis of thrombopathia using the “platelet osmotic-resistance test.” Brit. J. Haematol. 5: 302. 118 Ulutin, O. N. & M. Karaca. 1960. Investigations on the platelet defect of thrombopathia. In Proceedings of the VIIth Congress of the International Society of Hematology. Rome , 1958. Vol. 2: 868– 870. Grune & Stratton. New York , N. Y. 119 Horowitz, H. I. & D. O'Leary. 1965. Von Willebrand's disease: a critical evaluation of diagnostic criteria. N. Y. State J. Med. 65: 2236. 120 Marx, R. 1959. The problem of differentiating pseudohemophilias. In Hemophilia and Other Hemorrhagic States. K. M. Brinkhous, Ed.: 108– 121. International Symposium, Rome, 1958. North Carolina Press. Chapel Hill , N. C. 121 Bachmann, F. 1959. Vasculäre Hämophilie und Thrombopathie “von Willebrand-Jürgens.” Schweiz. Med. Wochenschr. 89: 1036. 122 Gugler, E. 1960. Angiohämophilie. Schweiz. Med. Wochenschr. 90: 534. 123 Jürgens, R. 1950. Experimentelles und Klinisches zur Pathogenese der hamorrhagischen Diathesen. Dtsch. Med. Wochenschr. 2: 1727. 124 Koch, F., H. E. Schultze & G. Schwick. 1958. Über eine hereditäre hamorrhagische Diathese mit verlangerter Blutungszeit, partiellem Mangel an antihämophilem Globulin A und einer funktionellen Stöning einzelner Thrombozytenfaktoren. Blut 4: 19. 125 Weiss, H. J. & L. M. Aledort. 1968. Patterns of abnormality in patients with prolonged bleeding time and in normal subjects after aspirin ingestion. (Abstr.) In Proceedings of the XIIth Congress of the International Society of Hematology (Abstracts of the Simultaneous Sessions): 198. New York , N.Y. 126 Zucker, M. B. & U. R. Levine. 1963. Microelectrophoresis of washed and unwashed human blood platelets, with additional studies of platelets from patients with von Willebrand's disease and thrombasthenia. Thromb. Diath. Haemorrh. 10: 1. 127 Najean, Y., N. Ardaillou, J. Caen, M.-J. Larrieu & J. Bernard 1963. Survival of radiochromium-labeled platelets in thrombocytopenias. Blood 22: 718. 128 Hogan, A. G., M. E. Muhrer & R. Bogart. 1941. A hemophilia-like disease in swine. Proc. Soc. Exp. Biol. Med. 48: 217. 129 Mertz, E. T. 1942. The anomaly of a normal Duke's and a very prolonged saline bleeding time in swine suffering from an inherited bleeding disease. Am. J. Physiol. 136: 360. 130 Brinkhous, K. M., F. C. Morrison, Jr. & M. E. Muhrer. 1952. Comparative study of clotting defects in human, canine and porcine hemophilia. Fed. Proc. 11 (Abstr.): 409. 131 Cornell, C. N. & M. E. Muhrer. 1964. Coagulation factors in normal and hemophiliac-type swine. Am. J. Physiol. 206: 926. 132 Muhrer, M. E., E. Lechler, C. N. CORNELL & J. L. Kirkland. 1965. Antihemophilic factor levels in bleeder swine following infusions of plasma and serum. Am. J. Physiol. 208: 508. 133 Chan, J. Y. S., C. A. Owen, Jr., E. J. W. Bowie, P. Didisheim, J. H. Thompson, Jr., M. E. Muhrer & P. E. Zollman. 1968. Von Willebrand disease “stimulating factor” in porcine plasma. Am. J. Physiol. 214: 1219. 134 Dodds, W. J. 1970. Canine von Willebrand's disease. J. Lab. Clin. Med. 76: 713. Citing Literature Volume201, Issue1Platelets and Their Role in HemostasisOctober 1972Pages 400-420 ReferencesRelatedInformation" @default.
• W2131741738 created "2016-06-24" @default.
• W2131741738 creator A5025594195 @default.
• W2131741738 creator A5085368010 @default.
• W2131741738 date "1972-10-01" @default.
• W2131741738 modified "2023-09-27" @default.
• W2131741738 title "PLATELET ABNORMALITIES IN VON WILLEBRAND'S DISEASE*" @default.
• W2131741738 cites W140535456 @default.
• W2131741738 cites W1480427406 @default.
• W2131741738 cites W1553166102 @default.
• W2131741738 cites W155573480 @default.
• W2131741738 cites W1967663708 @default.
• W2131741738 cites W1974023752 @default.
• W2131741738 cites W1975542913 @default.
• W2131741738 cites W1984412109 @default.
• W2131741738 cites W1992724611 @default.
• W2131741738 cites W1998114605 @default.
• W2131741738 cites W2001433760 @default.
• W2131741738 cites W2004947771 @default.
• W2131741738 cites W2005007756 @default.
• W2131741738 cites W2007360230 @default.
• W2131741738 cites W2007499970 @default.
• W2131741738 cites W2021334370 @default.
• W2131741738 cites W2023280452 @default.
• W2131741738 cites W2029663570 @default.
• W2131741738 cites W2039821144 @default.
• W2131741738 cites W2046313141 @default.
• W2131741738 cites W2053616627 @default.
• W2131741738 cites W2055424579 @default.
• W2131741738 cites W2058393392 @default.
• W2131741738 cites W2076455741 @default.
• W2131741738 cites W2077009438 @default.
• W2131741738 cites W2078694824 @default.
• W2131741738 cites W2079066174 @default.
• W2131741738 cites W2086633510 @default.
• W2131741738 cites W2089634550 @default.
• W2131741738 cites W2091177079 @default.
• W2131741738 cites W2094497537 @default.
• W2131741738 cites W2143189693 @default.
• W2131741738 cites W2148113183 @default.
• W2131741738 cites W2164787046 @default.
• W2131741738 cites W2217538658 @default.
• W2131741738 cites W2225112376 @default.
• W2131741738 cites W230817699 @default.
• W2131741738 cites W2313841860 @default.
• W2131741738 cites W2314189699 @default.
• W2131741738 cites W2316836708 @default.
• W2131741738 cites W2318457451 @default.
• W2131741738 cites W2319840592 @default.
• W2131741738 cites W2324042185 @default.
• W2131741738 cites W2325368353 @default.
• W2131741738 cites W2332701273 @default.
• W2131741738 cites W2333149001 @default.
• W2131741738 cites W2334390017 @default.
• W2131741738 cites W2335284732 @default.
• W2131741738 cites W2395230418 @default.
• W2131741738 cites W2400042544 @default.
• W2131741738 cites W2407225307 @default.
• W2131741738 cites W2412079422 @default.
• W2131741738 cites W2412877075 @default.
• W2131741738 cites W2413999496 @default.
• W2131741738 cites W2414972904 @default.
• W2131741738 cites W2415416659 @default.
• W2131741738 cites W2415496675 @default.
• W2131741738 cites W2417876606 @default.
• W2131741738 cites W2434510206 @default.
• W2131741738 cites W246220413 @default.
• W2131741738 cites W2472294508 @default.
• W2131741738 cites W2611361986 @default.
• W2131741738 cites W2805513465 @default.
• W2131741738 cites W2805992354 @default.
• W2131741738 cites W2809113909 @default.
• W2131741738 cites W2810195280 @default.
• W2131741738 cites W3024412946 @default.
• W2131741738 cites W3027632322 @default.
• W2131741738 cites W4230415263 @default.
• W2131741738 cites W4241188272 @default.
• W2131741738 cites W4299822935 @default.
• W2131741738 cites W987815580 @default.
• W2131741738 cites W2005299572 @default.
• W2131741738 cites W2065670690 @default.
• W2131741738 doi "https://doi.org/10.1111/j.1749-6632.1972.tb16313.x" @default.
• W2131741738 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/4539664" @default.
• W2131741738 hasPublicationYear "1972" @default.
• W2131741738 type Work @default.
• W2131741738 sameAs 2131741738 @default.
• W2131741738 citedByCount "14" @default.
• W2131741738 countsByYear W21317417382012 @default.
• W2131741738 crossrefType "journal-article" @default.
• W2131741738 hasAuthorship W2131741738A5025594195 @default.
• W2131741738 hasAuthorship W2131741738A5085368010 @default.
• W2131741738 hasConcept C203014093 @default.
• W2131741738 hasConcept C2778780528 @default.
• W2131741738 hasConcept C2779394231 @default.
• W2131741738 hasConcept C71924100 @default.
• W2131741738 hasConcept C89560881 @default.
• W2131741738 hasConceptScore W2131741738C203014093 @default.
• W2131741738 hasConceptScore W2131741738C2778780528 @default.

• next